Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.39 |
| ▸ | USP2 | O75604 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 3/20 | 0.33 |
| ▸ | CA1 | P00915 | 3/20 | 0.33 |
| ▸ | CA9 | Q16790 | 3/20 | 0.33 |
| ▸ | MGLL | Q99685 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
| ▸ | PHGDH | O43175 | 1/20 | 0.32 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.32 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.32 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.32 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3103737 | 1.00 | SMN1; SMN2 (0.39) | SMN1; SMN2USP2ALDH1A1RECQLTSHR | |
| SCHEMBL13076972 | 0.84 | — | — | |
| SCHEMBL23887411 | 0.83 | SMN1; SMN2 (0.39) | SMN1; SMN2USP2ALDH1A1RECQLTSHR | |
| SCHEMBL9420085 | 0.78 | — | — | |
| SCHEMBL4471161 | 0.77 | SMN1; SMN2 (0.37) | SMN1; SMN2USP2ALDH1A1RECQLTSHR | |
| SCHEMBL85406 | 0.77 | SMN1; SMN2 (0.37) | SMN1; SMN2USP2ALDH1A1RECQLTSHR | |
| SCHEMBL10997459 | 0.75 | ALDH1A1 (0.38) | SMN1; SMN2USP2ALDH1A1RECQLTSHR | |
| SCHEMBL10512747 | 0.75 | ALDH1A1 (0.38) | SMN1; SMN2USP2ALDH1A1RECQLTSHR | |
| SCHEMBL409231 | 0.74 | SMN1; SMN2 (0.40) | SMN1; SMN2USP2ALDH1A1RECQLTSHR | |
| SCHEMBL24590134 | 0.74 | SMN1; SMN2 (0.40) | SMN1; SMN2USP2ALDH1A1RECQLTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12534487-B2 | Compounds for use as iron(III) MRI contrast agents | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2026-01-27 | — | — | US | disclosed |
| US-20220259244-A1 | COMPOUNDS FOR USE AS IRON(III) MRI CONTRAST AGENTS | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK | 2022-08-18 | — | — | US | disclosed |
| US-11261208-B2 | Compounds for use as iron(III) MRI contrast agents | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2022-03-01 | — | — | US | disclosed |
| EP-3624859-A1 | COMPOUNDS FOR USE AS IRON(III) MRI CONTRAST AGENTS | The Research Foundation for The State University of New York (US) | 2020-03-25 | — | — | EP | disclosed |
| US-20200079806-A1 | COMPOUNDS FOR USE AS IRON(III) MRI CONTRAST AGENTS | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK | 2020-03-12 | — | — | US | disclosed |
| WO-2018213853-A1 | COMPOUNDS FOR USE AS IRON(III) MRI CONTRAST AGENTS | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2018-11-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200079806-A1 | COMPOUNDS FOR USE AS IRON(III) MRI CONTRAST AGENTS | FECH, HAMP, TFRC | SMN1; SMN2 2062/4885USP2 3836/4885ALDH1A1 4334/4885 |
| US-12534487-B2 | Compounds for use as iron(III) MRI contrast agents | SLC9A3, SLC9A2, SLC9A1 | SMN1; SMN2 1990/4885USP2 3484/4885ALDH1A1 4369/4885 |
| US-11261208-B2 | Compounds for use as iron(III) MRI contrast agents | FECH, HAMP, SLC40A1 | SMN1; SMN2 1874/4885USP2 3983/4885ALDH1A1 4378/4885 |
| US-20220259244-A1 | COMPOUNDS FOR USE AS IRON(III) MRI CONTRAST AGENTS | FECH, HAMP, SLC40A1 | SMN1; SMN2 1874/4885USP2 3983/4885ALDH1A1 4378/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.